Bath & Body Works (NYSE:BBWI) Receives Hold Rating from Argus

Argus reiterated their hold rating on shares of Bath & Body Works (NYSE:BBWI) in a research note released on Friday,Benzinga reports.

Other equities analysts also recently issued reports about the stock. Piper Sandler increased their price objective on Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a report on Monday, January 6th. Morgan Stanley cut their price target on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. JPMorgan Chase & Co. boosted their price target on Bath & Body Works from $35.00 to $39.00 and gave the company a “neutral” rating in a research note on Tuesday, November 26th. TD Cowen raised their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Finally, Barclays boosted their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, Bath & Body Works has a consensus rating of “Moderate Buy” and a consensus price target of $43.06.

Bath & Body Works Trading Down 1.4 %

Shares of Bath & Body Works stock opened at $36.45 on Friday. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99. The stock has a 50-day moving average price of $35.75 and a 200 day moving average price of $33.77. The company has a market cap of $7.89 billion, a P/E ratio of 8.89, a P/E/G ratio of 1.43 and a beta of 1.82.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.46 by $0.03. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the company posted $0.48 earnings per share. On average, equities analysts forecast that Bath & Body Works will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were paid a $0.20 dividend. The ex-dividend date was Friday, November 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.19%. Bath & Body Works’s payout ratio is 19.51%.

Hedge Funds Weigh In On Bath & Body Works

Large investors have recently bought and sold shares of the stock. True Wealth Design LLC grew its position in Bath & Body Works by 5,270.0% in the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after purchasing an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its stake in Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares during the period. Wilmington Savings Fund Society FSB acquired a new position in Bath & Body Works in the 3rd quarter valued at approximately $39,000. TD Private Client Wealth LLC lifted its position in shares of Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after acquiring an additional 331 shares during the period. Finally, Meeder Asset Management Inc. grew its holdings in shares of Bath & Body Works by 480.3% during the 3rd quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,436 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.